跳至主要内容
临床试验/NCT06445361
NCT06445361招募中不适用

The Prevalence of Non-Alcoholic Fatty Liver Disease in Type 1 Diabetes Mellitus Patients Followed at Ziekenhuis Oost-Limburg, Genk, Belgium

Ziekenhuis Oost-Limburg2 个研究点 分布在 1 个国家目标入组 138 人开始时间: 2023年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
138
试验地点
2
主要终点
Prevalence of fibrosis in T1DM

研究概览

简要总结

To determine the prevalence of NAFLD in T1DM patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥ 18 years of age
  • Written informed consent obtained

排除标准

  • Excessive alcohol use
  • Exclusion of other causes of liver disease and secondary causes of liver steatosis

结局指标

主要结局

Prevalence of fibrosis in T1DM

时间窗: During the intervention

To determine the prevalence of fibrosis in a cohort of T1DM patients followed at the Departments of Endocrinology in ZOL by means of the FibroScan® device with vibration controlled attenuation parameter (VCTE) measurements.

Prevalence of NAFLD in T1DM

时间窗: During the intervention

To determine the prevalence of steatosis in a cohort of T1DM patients followed at the Departments of Endocrinology in ZOL by means of the FibroScan® device with controlled attenuation parameter (CAP) measurements.

次要结局

未报告次要终点

研究者

发起方
Ziekenhuis Oost-Limburg
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验